Company: CSLMF
Filing Date: 2025-07-03
Form Type: DEFM14A
Source: 0001193125-25-155514
Chunk: 610

Company: CSLM ACQUISITION CORP.
Filing Date: 2025-07-03
Form: DEFM14A
Chunk 610
---
 events through the date of issuance of these consolidated financial statements, and determined that there
have been no events that have occurred that would require adjustments to disclosures in the consolidated financial statements except for the below items:

Amendment of the maturity date and conversion option

On January 31, 2025, the company entered into an amendment agreement of the convertible note payable to Dolma. Pursuant to the amendment
agreement, the maturity date was revised to February 28, 2026.

F-95

Pursuant to the amendment agreement, it was agreed that if the Company enters into a SPAC
Business Combination Agreement at any time while the Notes are outstanding, any portion of the Aggregate Notes Amount that is not redeemed or repaid in connection or prior to the closing of the SPAC Transaction will convert, without any required
action by the Holder, into shares of Common Stock immediately prior to the consummation of the SPAC Transaction contemplated by the SPAC Business Combination Agreement at a conversion rate that is derived from a Company valuation of $85,000,000, on
a fully-diluted basis (provided that the Notes will be deemed have converted simultaneously with all other convertible notes being converted in connection the SPAC Transaction)

Revision of PIPE investment amount

On
February 4, 2025, CSLM entered into a second amendment to the original merger agreement dated January 22, 2024 to amend the definition of the “PIPE Investment amount” to mean the sum of (i) $8,840,000 and (ii) the contingent
PIPE Investment amount, if any.

Waiver of covenant fees

On February 4, 2025, the company, CSLM Acquisition Corp. and CSLM merger sub inc. entered into a second amendment to the original merger
agreement dated January 22, 2024. The amendment specifically deleted Section 7.3 of the original agreement, which had stipulated a delay fee in the event the Company failed to deliver the audited 2023 financial statements to the CSLM by
the PCAOB audit deadline.

Under the terms of the original agreement, the Company was required to provide the audited financial statements
no later than February 29, 2024, or incur delay fees as mentioned in the agreement.

The Company had covenanted to provide the
audited financial statements no later than February 29, 2024, however, provided the audited financial statements to CSLM in September 2024. As a result